To determine efficacy and safety of OnabotulinumtoxinA (BoNT-A) injection therapy in medically refractory patients with lower urinary tract symptoms (LUTS) due to primary bladder-neck dysfunction (PBND).
Sacco, E., Tienforti, D., Bientinesi, R., D'Addessi, A., Racioppi, M., Pinto, F., Totaro, A., Vittori, M., D'Agostino, D., Bassi, P., OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes, <<NEUROUROLOGY AND URODYNAMICS>>, 2014; 33 (1): 142-146. [doi:10.1002/nau.22393] [http://hdl.handle.net/10807/52162]
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes
Sacco, Emilio;Tienforti, Daniele;Bientinesi, Riccardo;D'Addessi, Alessandro;Racioppi, Marco;Pinto, Francesco;Totaro, Angelo;Vittori, Matteo;D'Agostino, Daniele;Bassi, Pierfrancesco
2014
Abstract
To determine efficacy and safety of OnabotulinumtoxinA (BoNT-A) injection therapy in medically refractory patients with lower urinary tract symptoms (LUTS) due to primary bladder-neck dysfunction (PBND).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
